Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pilot study of p62 DNA vaccine in dogs with mammary tumors

25 Sept 2014

Abstract excerpt

// Vladimir Gabai 1,* , Franco M. Venanzi 2,* , Elena Bagashova 3 , Oksana Rud 3 , Francesca Mariotti 2 , Cecilia Vullo 2 , Giuseppe Catone 2 , Michael Y. Sherman 4 , Antonio Concetti 2 , Andrey Chursov 1 , Anastasia Latanova 1,5 , Vita Shcherbinina 1,5 , Victor Shifrin 1,* and Alexander Shneider 1,5 1 CureLab Oncology Inc, Needham MA, USA 2 School of Biosciences and Veterinary Medicine University of Camerino,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Veterinary Oncology Research
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25296974
DOI: 10.18632/oncotarget.2516

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pilot study of p62 DNA vaccine in dogs with mammary tumorsPMID 25296974Read ↗

p62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunitySemantic proximity Read ↗

Safety and Efficacy of a Genetic Vaccine Targeting Telomerase Plus Chemotherapy for the Therapy of Canine B-Cell LymphomaSemantic proximity Read ↗

Efficacy of p62-expressing plasmid in treatment of canine ATOPIC DERMATITIS: A Pilot study IN companion dogsSemantic proximity Read ↗

The caninized anti-canine PD-1 monoclonal antibody in canine oral malignant melanoma: Efficacy and exploratory biomarker analysisSemantic proximity Read ↗

Establishment and characterization of a tumoroid biobank derived from dog patients’ mammary tumors for translational researchSemantic proximity Read ↗

Canine Parvovirus and Its Non-Structural Gene 1 as Oncolytic Agents: Mechanism of Action and Induction of Anti-Tumor Immune ResponseSemantic proximity Read ↗

CAR T-Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds against Hematological MalignanciesSemantic proximity Read ↗

Therapeutic applications of topical injection of hsa-miR-634 into canine spontaneous malignant melanoma tumorsSemantic proximity Read ↗

Involvement of Epithelial to Mesenchymal Transition in Canine Mammary Tumor ProgressionSemantic proximity Read ↗

Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcomaSemantic proximity Read ↗

Preclinical SC and IV repeat-dose toxicology of a cowpea mosaic virus – A cancer immunotherapy candidateSemantic proximity Read ↗

Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy Beagle dogsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.